Ref.: BL-RE-105988Manufacturer ref.: EHKLK14X5 5 x 96 tests
€2,950.00 excl. VAT
Kit ELISA Kallikrein 14 sandwich (Hu KLK14) (human): quantitative determination of Hu KLK14 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK14.
Accession number
Q9P0G3
Dose range
2.05 pg/ml to 500 pg/ml
Sensitivity of the dosage
1.5 pg/ml
Calibration range
1.5 pg/ml to 500 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA Kallikrein 14 sandwich (Hu KLK14) (human): quantitative determination of Hu KLK14 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK14.
Kit ELISA Kallikrein 14 sandwich (Hu KLK14) (human): quantitative determination of Hu KLK14 in serum, plasma or cell culture medium. The test recognizes only the natural and recombinant forms of Hu KLK14.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
Serine endopeptidase with a double substrate specificity similar to trypsin and chymotrypsin. May activate/disactivating receptors activated by proteinase F2R, F2RL1 and F2RL3 and other kalliderins, including KLK1, KLK3, KLK5 and KLK11. Can function by liquefaction of the seminal clot by direct cleavage of the semenogeline SEMG1 and SEMG2 and activation of KLK3. Can work through the DSG1 cleavage of desmoglein in epidermal desquamation. This is a process by which the most superficial corneocytes are placed on the skin surface. May be involved in several aspects of tumour progression, including growth, invasion and angiogenesis.
Sensitivity
Sensitivity of the dosage: 1.5 pg/ml.
Measurement range
Dose range: 2.05 pg/ml to 500 pg/ml.
Duration of dosing
Total dosage duration: 4 hours 45 min.
Specificity
This ELISA antibody detects human KLK14. Other species not yet determined.